Communication and Marketing of School Meals

计划入组 711 人 · 首次发布于 2021 年 11 月 5 日

A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis (DCM ) Treated With Olorofim Plus Baseline SOC or Placebo Plus Baseline SOC

计划入组 50 人 · 首次发布于 2026 年 7 月 17 日

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

计划入组 53 人 · 首次发布于 2005 年 9 月 1 日

HIROSHIMA JOGAKUIN UNIVERSITY

Japan

Johnson & Johnson's Executive Leadership: The Architects Behind the Kenvue Separation and Innovative Medicine Growth

Eli Lilly CEO David Ricks Tops Pharma Executive Compensation at $29.2 Million in 2024

Johnson & Johnson Reports 9.1% Q4 Sales Growth, Targets $100.5 Billion Revenue for 2026